Improving Clinical Trial Patient Diversity: Can Central Imaging Play a Role?
Rare Disease Patients Overlooked During COVID
5 Ways DCTs Can Positively Impact Trial Diversity
The Many Paths of Diversity in Clinical Trials
Contemplating the Full Measure of Pandemic Response
Shifting from Paper to Digital Patient Consent
The Tangled Web of Large Outsourced Providers
Clinical Trials Diversity and Inclusion
Applied Clinical Trials June 2021 Issue (PDF)
Is COVID A Game-Changer for Wider Drug Development Policy?
FDA Promotes Master Protocols to Modernize Clinical Trials
Steps Toward Diversity in Clinical Trials: Building Authentic Trust